Quinidine Gluconate (Eli Lilly and Company)


Welcome to the PulseAid listing for the Quinidine Gluconate drug offered from Eli Lilly and Company. This Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Eli Lilly and Company
NON-PROPRIETARY NAME: Quinidine Gluconate
SUBSTANCE NAME: QUINIDINE GLUCONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiarrhythmic [EPC],Cytochrome P450 2D6 Inhibitor [EPC],Cytochrome P450 2D6 Inhibitors [MoA]
ROUTE: INTRAVENOUS
DOSAGE FORM: SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 1950-07-12
END MARKETING DATE: 0000-00-00


Quinidine Gluconate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionQuinidine Gluconate from Eli Lilly and Company
LABELER NAME: Eli Lilly and Company
DEA SCHEDULE:
ACTIVE STRENGTH: 80(mg/mL)
START MARKETING DATE: 1950-07-12
END MARKETING DATE: 0000-00-00
PRODUCT ID: 0002-1407_14757f9d-f641-4836-acf3-229265588d1d
PRODUCT NDC: 0002-1407
APPLICATION NUMBER: NDA007529

Other QUINIDINE GLUCONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Carilion Materials ManagementQuinidine Gluconate
Eli Lilly and CompanyQuinidine Gluconate
Richmond Pharmaceuticals, Inc.Quinidine Gluconate
Sun Pharmaceutical Industries, Inc.Quinidine Gluconate